A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

24.8K views

⸱

DOI:

10.3791/52933

⸱

June 19th, 2015

 ,  ,  ,  ,  ,  ,  , 

In This Article

Summary

Neutrophils play an important role not only in host defense against invading microorganisms, but are also involved in the immune surveillance of tumor cells. Here, we describe techniques related to the isolation of neutrophils with anti-tumor properties and methods for monitoring anti-tumor neutrophil function in vitro and in vivo.

Abstract

Neutrophils, the most abundant of all white blood cells in the human circulation, play an important role in the host defense against invading microorganisms. In addition, neutrophils play a central role in the immune surveillance of tumor cells. They have the ability to recognize tumor cells and induce tumor cell death either through a cell contact-dependent mechanism involving hydrogen peroxide or through antibody-dependent cell-mediated cytotoxicity (ADCC). Neutrophils with anti-tumor activity can be isolated from peripheral blood of cancer patients and of tumor-bearing mice. These neutrophils are termed tumor-entrained neutrophils (TEN) to distinguish them from neutrophils of healthy subjects or naïve mice that show no significant tumor cytotoxic activity. Compared with other white blood cells, neutrophils show different buoyancy making it feasible to obtain a > 98% pure neutrophil population when subjected to a density gradient. However, in addition to the normal high-density neutrophil population (HDN), in cancer patients, in tumor-bearing mice, as well as under chronic inflammatory conditions, distinct low-density neutrophil populations (LDN) appear in the circulation. LDN co-purify with the mononuclear fraction and can be separated from mononuclear cells using either positive or negative selection strategies. Once the purity of the isolated neutrophils is determined by flow cytometry, they can be used for in vitro and in vivo functional assays. We describe techniques for monitoring the anti-tumor activity of neutrophils, their ability to migrate and to produce reactive oxygen species, as well as monitoring their phagocytic capacity ex vivo. We further describe techniques to label the neutrophils for in vivo tracking, and to determine their anti-metastatic capacity in vivo. All these techniques are essential for understanding how to obtain and characterize neutrophils with anti-tumor function.

Introduction

Neutrophils were initially characterized as the innate immune cells which serve as first line defense against invading microorganisms. Today it is known that neutrophils have more far-reaching functions, being involved in mounting adaptive immune responses against foreign antigens1,2, regulating hematopoiesis3, angiogenesis4 and wound healing5. In addition, neutrophils may affect tumor growth and metastatic progression by virtue of their pro- and anti-tumor activities6,7. Neutrophils are characterized by a polymorphic segmented nucleus (hence termed polymorphonuclear (PMN) leukocytes) and contain at least three di....

Access restricted. Please log in or start a trial to view this content.

Protocol

Animals: 5-7 weeks old BALB/c mice are purchased from Harlan (Israel). All experiments involving animals were approved by the Hebrew University’s Institutional Animal Care and Use Committee (IACUC). Human samples: Collection of blood from cancer patients and healthy volunteers was approved by Hadassah Medical Center Institutional Review Board (IRB).  

1. Induction of Neutrophils with Anti-tumor Properties in vivo Using a Breast Cancer Mouse Model.

NOTE: All steps should be performed using sterile solutions in a laminar airflow (LAF) Bio-Safety cabinet.

  1. Seed 5 x 105 4T1 c....

Access restricted. Please log in or start a trial to view this content.

Results

In a recent study we identified an anti-metastatic function for neutrophils6. Neutrophils from tumor-bearing mice acquire a cytotoxic phenotype and have the capacity to kill tumor cells6. This is in contrast to neutrophils from naïve mice that have no significant anti-tumor effect6. Several of the techniques described in the Protocol Section have been used for studying anti-tumor neutrophil function in vitro and in vivo6.

Tumor cyto.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Neutrophils are the most abundant of all white blood cells and are the first responders in cases of infection and inflammation. As such, they are highly sensitive to external cues and are easily activated. In addition, neutrophils have a very short half-life and a rapid turnover. Together, these characteristics raise several difficulties in working with neutrophils, such that unique experimental strategies are required. For example, there are several neutrophil purification strategies, each with its own pros and cons.

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

ZG is supported by grants from the I-CORE Program of The Israel Science Foundation (Grant No. 41/11), the Abisch-Frenkel Foundation, the Rosetrees Trust, the Israel Cancer Research Foundation (ICRF - Research Career Development Award) and the CONCERN foundation. ZGF is supported by grants from the Israel Cancer Research Foundation (ICRF - Research Career Development Award), Chief Scientist of the Israel Ministry of Health and the Israel Lung Association.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
CELL LINES
Mouse 4T1 breast carcinoma cellsADCCCRL-2539Growth medium: DMEM + 10 % heat-inactivated FBS
PLASTIC WARES AND EQUIPMENTS
24-well Tissue Culture Plate Falcon353047Sterile
100 mm Tissue Culture Plate Corning430167Sterile
25 cm2 Tissue Culture FlaskNunc156340Sterile
90 mm Bacterial Grade Culture Dish Miniplast, Ein Shemer, Israel20090-01-017Sterile
15 ml Sterile Conical Centrifuge Tube Miniplast, Ein Shemer, Israel835015-40-111Sterile
50 ml Sterile Conical Centrifuge Tube Miniplast, Ein Shemer, Israel835050-21-111Sterile
Falcon 12 x 75 mm Round-Bottom Polystyrene Tube Becton Dickinson352058Sterile
Millicell 24 Migration Plate with a pore size of 5μm Merck MilliporePSMT010R1Sterile
White 96-Flat-Bottom Well Plate Costar3917Sterile
Cell Strainer (40 mm) BD Falcon352340Sterile
20G x 1.5" NeedleBD Microlance 3 301300Sterile
23G x 1" Needle BD Microlance 4300800Sterile
25G x 5/8" Needle BD Microlance 5300600Sterile
0.3 ml Syringe with a 30G x 8mm NeedleBD Micro-Fine Plus Demi320829Sterile
9 mm Clips BD, AutoClip 427631Sterile
EasySep Magnet STEMCELL Technologies18000
MACS LS Separation Column Miltenyi Biotech130-042-201Sterile
MidiMACS Separator MagnetMiltenyi Biotech130-042-302
MACS MultiStandMiltenyi Biotech130-042-303
Microscope Glass Slide Menzel-Gläser Superfrost  Plus ThermoJ1800AMNZ
Orbital Shaker Sky line, ELMIS-3.02.10L
Plate Reader TECANInfiniteF200Pro
POWDER
Bovine serum albumin (BSA), fraction VSigmaA7906
Bromodeoxyuridine (BrdU) BD Pharmingen550891Sterile
CFSE (5-(and 6-)-Carboxyfluorescein diacetate, succinimidyl ester)Molecular ProbesC1157
Dextran T500Sigma31392
Heparin sodium salt from porcine intestinal mucosa SigmaH3149
Sodium azide (NaN3)SigmaS8032Highly toxic, handle with care
Thioglycollate powder Difco225650
Zymosan ASigmaZ4250
MEDIA AND SUPPLEMENTS
Dulbecco's modified Eagle medium (DMEM)SigmaD5796Sterile
Opti-MEM® I reduced serum medium Life Technologies31985062Sterile
Roswell Park Memorial Institute (RPMI)-1640 mediumSigmaR8758Sterile
Foetal bovine serum (FBS), heat-inactivatedSigmaF9665Sterile
L-GlutamineBiological Industries, Beth HaEmek, Israel03-020-1ASterile
Sodium pyruvateBiological Industries, Beth HaEmek, Israel03-042-1BSterile
Penicillin Streptomycin x 1000 solutionBiological Industries, Beth HaEmek, Israel03-031-5Sterile
Phosphate buffered saline (PBS) without Mg2+ and Ca2+ Biological Industries, Beth HaEmek, Israel02-023-1Sterile
PBS x 10 without Ca2+ and Mg2+ Biological Industries, Beth HaEmek, Israel02-023-5ASterile
HPLC grade water J.T. Baker4218-03Autoclave
SOLUTIONS
ACK – Ammonium-Chloride-PotassiumLife Technologies A10492-01
Bromodeoxyuridine (BrdU) solution (10 mg/ml) in PBSDissolve 10 mg of BrdU in 1 ml PBS and sterile filter.
CFSE, 5 mM in DMSODissolve 2.8 mg of CFSE in 1 ml DMSO. Divide into 10 ml aliquots in sterile 200 ml tubes and store in the dark at -20oC.
Eosin Y solutionSigmaHT110-2-32
Hanks' balanced salt solutionBiological Industries, Beth HaEmek, Israel02-016-1ASterile
Heparin, 20 mg/ml in PBSDissolve 100 mg Heparin in 5 ml sterile PBS, and sterile filter through a 0.2 mm filter. 
Histopaque-1119 Sigma11191Sterile filter through a 0.2 mm filter.
Histopaque-1077 Sigma10771Sterile filter through a 0.2 mm filter.
Luciferase cell culture lysis buffer x5PromegaE153ADilute 1:5 in sterile water just before use.
Luciferase assay solutionPromegaE1501Contains luciferase assay substrate powder (E151A) and luciferase assay buffer (E152A)
Mayer's Hematoxylin solution SigmaMHS-32
PBS + 0.5% BSADissolve 2.5 g BSA in 500 ml PBS, and sterile filter through a 0.2 mm filter.
PBS + 1% BSADissolve 1g BSA in 100 ml PBS, and sterile filter through a 0.2 mm filter.
5x PBS with 2.5% BSADissolve 12.5g BSA in a mixture of 250 ml sterile HPLC-grade water and 250 ml PBSx10, and sterile filter through a 0.2 mm filter.
PBS containing 0.5% BSA and 2 mM EDTADissolve 250 mg BSA in 50 ml sterile PBS and add 200 ml of 0.5M EDTA pH 8.0, sterile filter through a 0.2 mm filter.
FACS buffer (PBS containing 0.5% BSA, 2 mM EDTA and 0.02% NaN3)Dissolve 250 mg BSA in 50 ml sterile PBS  and add 200 ml of 0.5M EDTA pH 8.0 and 500 ml of 2% NaN3, sterile filter through a 0.2 mm filter.
Saline (0.9% NaCl)Dissolve 9 g NaCl in 1,000 ml ddw, autoclave
0.2% NaCl solutionDissolve 2 g NaCl in 1,000 ml ddw, autoclave
1.6% NaCl solutionDissolve 16 g NaCl in 1,000 ml ddw, autoclave
2 % Sodium azideDissolve 1g sodium azide in 50 ml sterile ddw, keep at 4oC. Highly toxic.
3% Thioglycollate solution                                       Dissolve 3 g of thioglycollate powder in 100 ml ddw.                                        Boil until solution becomes yellow and autoclave.
Trypan blue solution (0.4%)SigmaT8154Dilute 1:10 in PBS to get a 0.04% solution.
Trypsin solution B Biological Industries, Beth HaEmek, Israel03-046-1Sterile
1 mg/ml Zymosan AResuspend 1 mg Zymosan A in 1 ml sterile PBS in an Eppendorf tube. Vortex vigorously and incubate the tube at 37 oC for 30 min. Do not autoclave. Prepare the solution freshly before use.
KITS
EasySep PE selection kitSTEMCELL Technologies18557
EasySep PE selection cocktail STEMCELL Technologies18151
the EasySep magnetic nanoparticles STEMCELL Technologies18150
Anti-Ly6G mouse MicroBead KitMiltenyi Biotec130-092-332
EasySep Mouse Neutrophil Enrichment KitSTEMCELL Technologies19762
EasySep Human Neutrophil Enrichment KitSTEMCELL Technologies19257
FITC BrdU flow kitBD Pharmingen 559619
MACS Neutrophil isolation kitMiltenyi Biotec130-097-658
Phagocytosis Assay Kit Cayman Chemical Company 500290
ANTIBODIES
FcR blocking antibody Biolegend101302
Purified rat anti-Ly6G antibody BD Pharmingen 551459Clone 1A8
PE-conjugated rat anti-mouse Ly6G antibody Biolegend127608Clone 1A8
FITC-conjugated rat anti-mouse Ly6GBD Pharmingen 551460Clone 1A8
PerCP-Cy5.5 rat anti-mouse Ly6G TONBO Biosciences65-1276Clone 1A8
violetFluor 450-conjugated rat anti-mouse Ly6G TONBO Biosciences75-1276Clone 1A8
FITC-conjugated rat anti-mouse CD11bBD Pharmingen 553310Clone M1/70
FITC-conjugated rat anti-mouse Ly-6G and Ly-6C (GR-1)BD Pharmingen 553127Clone RB6-8C5
PE-conjugated rat anti-mouse CD45BD Pharmingen 553081Clone 30-F11
FITC-conjugated rat anti-mouse F4/80 Abcamab60343Clone BM8
FITC-conjugated mouse anti-human CD66b Biolegend305103Clone G10F5
Purified rat isotype control antibody (IgG2a, k) BD Pharmingen 553927Clone R35-95
LEAF purified Armenian hamster anti-mouse CD3e antibodyBioLegend100314Clone 145-2C11

References

  1. Tangye, S. G., Brink, R. A helping hand from neutrophils in T cell-independent antibody responses. Nat Immunol. 13, 111-113 (2012).
  2. Mantovani, A., Cassatella, M. A., Costantini, C., Jaillon, S. Neutrophils in the activation and regulation of innate and adaptive immun....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Neutrophil IsolationDensity GradientTumor Entrained NeutrophilsLow Density NeutrophilsHigh Density NeutrophilsFlow CytometryLuciferase AssayCell CytotoxicityReactive Oxygen SpeciesPhagocytic Capacity